Silo Pharma, Inc. / Fundamentals
Income statement
- Net revenue
€62.19K - Cost of goods sold
€5.04K - Gross profit
€57.16K - SG&A expenses
€1.23M - R&D expenses
€2.51M - EBITDA
-€4.36M - D&A
€7.47K - EBIT
-€4.46M - Interest expenses
-€2.03K - EBT
-€4.22M - Tax expenses
€0.00 - Net income
-€4.22M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€2.13M - Changes in working capital
€472.49K - Operating cash flow
-€4.48M - Capex
€2.59 - Other investing cash flow
€1.09M - Net investing cash flow
€1.02M - Total cash dividends paid
€0.00 - Issuance of common stock
€3.31M - Debt repayment
€0.00 - Other financing cash flow
€1.50M - Net financing cash flow
€3.31M - Foreign exchange effects
€0.00 - Net change in cash
-€148.91K - Cash at end of period
€3.74M - Free cash flow
-€4.48M
Balance sheet
- Cash and cash equivalents
€3.74M - Cash and short-term investments
€5.40M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€97.53K - Total current assets
€5.50M - Property, plant & equipment
€0.00 - Goodwill
€0.00 - Intangible assets
€192.57K - Long-term investments
€0.00 - Other non-current assets
-€5.45M - Total non-current assets
-€5.26M - Total assets
€5.74M - Accounts payable
€843.44K - Short-term debt
€0.00 - Other current liabilities
€0.00 - Total current liabilities
€905.63K - Long-term debt
€0.00 - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€591.33K - Total liabilities
€1.50M - Common stock
€746.14 - Retained earnings
-€15.10M - Other equity
€8.25K - Total equity
€4.24M - Total liabilities and shareholders' equity
€5.74M
Company information
- Market capitalization
€3.94M - Employees
3 - Enterprise Value
€1.12M
Company ratios
- Gross margin
-
91.9% Much worse than peer group: 137,802,520,687,132,380.0% - EBITDA margin
-
-7,015.7% Much worse than peer group: 5,101,858,965,149,129,000.0% - EBIT margin
-
-7,165.0% Much worse than peer group: 5,475,139,268,353,223,000.0% - EBT margin
-
-6,789.2% Much worse than peer group: 5,673,538,150,803,845,000.0% - Net margin
-
-6,789.2% Much worse than peer group: 2,133,946,780,268,117,600.0% - ROE
-
-99.6% Much better than peer group: -136.8% - ROA
-
-73.6% Much better than peer group: -230.9% - Asset turnover
-
1.1% Much worse than peer group: 559.2% - FCF margin
-
-7,197.4% Much worse than peer group: 3,257,161,346,136,870,800.0% - FCF yield
-113.6% - Efficiency ratio
7,115.7% - Net sales per employee
-
€20.73K - Net income per employee
-
-€1.41M